Stay updated on Dupilumab in Children With Asthma Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Children With Asthma Clinical Trial page.

Latest updates to the Dupilumab in Children With Asthma Clinical Trial page
- Check4 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2. The study record remains unavailable on the page.SummaryDifference0.2%

- Check11 days agoChange DetectedA site-wide banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check18 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check25 days agoChange DetectedThe ClinicalTrials.gov page remains a 403 Forbidden error page; its footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page now presents a 403 Forbidden error, replacing the expected study content with a minimal error screen. This indicates access to the study record is blocked, while the site chrome remains visible.SummaryDifference19%

- Check53 days agoChange DetectedA new publication citation was added under Publications, referencing a 2026 J Allergy Clin Immunol article on dupilumab outcomes in pediatric asthma. This expands the study's bibliographic references without altering core study details.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in Children With Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Children With Asthma Clinical Trial page.